510(k) Report

510(k) · Cleared

Cleared

Universal Taper Delta Femoral Head

K070885510(k) TraditionalCleared May 16, 200747-day reviewClass II21 CFR 888.3353

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Howmedica Osteonics Corp. · LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented

Cleared on May 16, 2007 after a 47-day review. The FDA summary names no predicate by number. 54 later devices descend from it.

Decided
May 16, 2007
Review
47 days
Class
Class II
Product code
LZO
Recalls
None
Predicates
0

54 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2016: 4 descendants cleared2007: 1 descendant cleared2011: 1 descendant cleared2017: 2 descendants cleared2008: 1 descendant cleared2024: 5 descendants cleared2015: 1 descendant cleared2018: 4 descendants cleared2020: 3 descendants cleared2019: 5 descendants cleared2022: 6 descendants cleared2021: 4 descendants cleared2023: 4 descendants cleared2013: 1 descendant cleared2014: 1 descendant cleared2026: 4 descendants cleared2025: 7 descendants cleared20052010201520202025
  1. This deviceK070885 Universal Taper Delta Femoral HeadHowmedica Osteonics Corp. · 2007
  2. Descendant · cites it directly · 37 of its ownK110290 Exeter Hip StemHowmedica Osteonics Corp. · 2011 · Recalled
  3. Descendant · cites it directly · 17 of its ownK153345 Stryker Orthopaedics Hip Systems Labeling UpdateStryker Orthopaedics · 2016 · Recalled
  4. Descendant · cites it directly · 14 of its ownK071830 Depuy Delta TS Ceramic Femoral HeadsDePuy Orthopaedics, Inc. · 2007 · Recalled
  5. Descendant · 2 generations on · 8 of its ownK173499 Exeter V40 Femoral Stem Hip System, Orthinox V40 Femoral HeadsStryker Orthopaedics · 2018 · Recalled
  6. Descendant · 2 generations on · 7 of its ownK182468 Trident X3 Acetabular Inserts, ADM and MDM X3 Acetabular Inserts…Howmedica Osteonics Corp. A.K.A. Stryker Orthopaedics · 2019

Showing 5 of 54 descendants. See all descendants

Descendants cleared per year

2007: 12008: 12011: 12013: 12014: 12015: 12016: 42017: 22018: 42019: 52020: 32021: 42022: 62023: 42024: 52025: 72026: 4
2007high 7 (2025) · low 0 (2009)2026

Most influential descendants

Showing 5 of 54 · See all
  • K110290Exeter Hip StemHowmedica Osteonics Corp. · 2011 · cites it directly37descendants
  • K153345Stryker Orthopaedics Hip Systems Labeling UpdateStryker Orthopaedics · 2016 · cites it directly17descendants
  • K071830Depuy Delta TS Ceramic Femoral HeadsDePuy Orthopaedics, Inc. · 2007 · cites it directly14descendants
  • K173499Exeter V40 Femoral Stem Hip System, Orthinox V40 Femoral HeadsStryker Orthopaedics · 2018 · 2 generations on8descendants
  • K182468Trident X3 Acetabular Inserts, ADM and MDM X3 Acetabular Inserts, Accolade II Hip SystemHowmedica Osteonics Corp. A.K.A. Stryker Orthopaedics · 2019 · 2 generations on7descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K070885Universal Taper Delta Femoral HeadHowmedica Osteonics Corp.2007—
+1K110290Exeter Hip StemHowmedica Osteonics Corp.20111
+1K153345Stryker Orthopaedics Hip Systems Labeling UpdateStryker Orthopaedics20161
+1K071830Depuy Delta TS Ceramic Femoral HeadsDePuy Orthopaedics, Inc.20071
+2K173499Exeter V40 Femoral Stem Hip System, Orthinox V40 Femoral HeadsStryker Orthopaedics20182
+2K182468Trident X3 Acetabular Inserts, ADM and MDM X3 Acetabular Inserts, Accolade II…Howmedica Osteonics Corp. A.K.A. Stryker Orthopaedics2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
200810
201110
201310
201410
201510
201640
201720
201840
201950
202030
202140
202260
202340
202450
202570
202640
FIG. 1 — Lineage of K070885, 2007–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZO device

  1. #1 K192827 Quadra-Pscore 19.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (54)

See all 54

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K110290Exeter Hip StemHowmedica Osteonics Corp.201137
K153345Stryker Orthopaedics Hip Systems Labeling UpdateStryker Orthopaedics201617
K071830Depuy Delta TS Ceramic Femoral HeadsDePuy Orthopaedics, Inc.200714
K162125MALUC™ Total Hip Arthroplasty SystemSurgtech, Inc.20170

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K110290 (Howmedica Osteonics Corp., 2011) has gone furthest, with 37 descendants of its own.

How does its category compare?

All LZO devices

LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · LZO

14in 2025

2007: 92008: 112009: 72010: 152011: 132012: 142013: 262014: 132015: 122016: 102017: 162018: 182019: 282020: 182021: 122022: 112023: 102024: 112025: 142026 (partial year): 9
2007high 28 (2019) · low 7 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZO

119in 2025

2007: 87 days median2008: 63 days median2009: 83 days median2010: 78 days median2011: 87 days median2012: 98 days median2013: 100 days median2014: 85 days median2015: 115 days median2016: 177 days median2017: 257 days median2018: 163 days median2019: 109 days median2020: 112 days median2021: 170 days median2022: 279 days median2023: 122 days median2024: 111 days median2025: 119 days median2026 (partial year): 102 days median
2007high 279 (2022) · low 63 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZO

1in 2025

2007: 22008: 132009: 422011: 102012: 142014: 12015: 12016: 92017: 52018: 22019: 42020: 32022: 42023: 22024: 12025: 1
2007high 42 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZO

3,244in 2025

2007: 1382008: 1252009: 1892010: 3942011: 5442012: 9632013: 1,3702014: 1,4772015: 1,3482016: 1,7282017: 2,1652018: 3,1332019: 3,0662020: 1,9632021: 2,1992022: 1,9852023: 2,0662024: 2,5862025: 3,244
2007high 3,244 (2025) · low 125 (2008)2025

MAUDE reports naming product code LZO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20079872138
2008116313125
200978342189
201015780394
2011138710544
2012149814963
20132610001,370
2014138511,477
20151211511,348
20161017791,728
20171625752,165
20181816323,133
20192810943,066
20201811231,963
20211217002,199
20221127941,985
20231012222,066
20241111112,586
20251411913,244
202691020—

What is it indicated for?

The femoral heads are intended for mechanical fixation to their mating hip stems, and can be used in cemented or cementless hip arthroplasty procedures. Indications for Use as a Bipolar · Femoral head/neck fractures or non-unions, · Aseptic necrosis of the femoral head, * Osteo-, rheumatoid, and post traumatic arthritis of the hip with minimal acetabular involvement or distortion, Pathological conditions or age considerations that indicate a more…

Read the full statement (170 words)

The femoral heads are intended for mechanical fixation to their mating hip stems, and can be used in cemented or cementless hip arthroplasty procedures.

Indications for Use as a Bipolar

· Femoral head/neck fractures or non-unions,

· Aseptic necrosis of the femoral head,

* Osteo-, rheumatoid, and post traumatic arthritis of the hip with minimal acetabular involvement or distortion,

Pathological conditions or age considerations that indicate a more conservative acetabular procedure and an avoidance of the use of bone cement in the acetabulum,

* Salvage of failed total hip arthroplasty.

Indications for Use as a Total Hip:

* Painful disabling joint disease of the hip resulting from: degenerative arthritis, rheumatoid arthritis, post-traumatic arthritis or late stage avascular necrosis,

* Revision of previous unsuccessful femoral head replacement, cup arthroplasty or other procedure,

* Clinical management problems where arthrodesis or alternative reconstructive techniques are less likely to achieve satisfactory results,

* Where bone stock is of poor quality or is inadequate for other reconstructive techniques as indicated by deficiencies in the acetabulum.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070885: Universal Taper Delta Femoral Head.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K070885

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026